Chronic airway disease: the infection connection.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2194299)

Published in Trans Am Clin Climatol Assoc on January 01, 1999

Authors

S B Greenberg1, R L Atmar

Author Affiliations

1: Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.

Articles cited by this

The natural history of chronic airflow obstruction. Br Med J (1977) 13.04

Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med (1968) 7.13

Respiratory viruses and exacerbations of asthma in adults. BMJ (1993) 6.37

Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med (1989) 6.22

The factor of infection in chronic bronchitis. Q J Med (1953) 4.47

The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22

Patterns of asthma mortality in Philadelphia from 1969 to 1991. N Engl J Med (1994) 3.28

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10

Respiratory viral infection and wheezy bronchitis in childhood. Thorax (1979) 3.01

The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med (1987) 2.43

Infective factors in exacerbations of bronchitis and asthma. Br Med J (1972) 2.41

A VIROLOGIC STUDY OF CHRONIC BRONCHITIS. N Engl J Med (1964) 2.28

Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy (1992) 2.28

Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25

RESPIRATORY SYNCYTIAL VIRUS IN ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS. Lancet (1963) 2.06

Inner-city asthma. The epidemiology of an emerging US public health concern. Chest (1992) 1.99

Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97

Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81

Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J (1997) 1.79

The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy (1970) 1.70

Dual respiratory virus infections. Clin Infect Dis (1997) 1.67

Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest (1996) 1.66

Association of viral and mycoplasma infections with exacerbations of asthma. Ann Allergy (1974) 1.52

Rhinovirus infection in acute exacerbations of chronic bronchitis: a controlled prospective study. Br Med J (1967) 1.49

Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med (1997) 1.44

INFECTION WITH INFLUENZA AND PARAINFLUENZA VIRUSES IN CRONIC BRONCHITIS. Thorax (1965) 1.40

Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis (1976) 1.33

CLINICAL TYPES OF CHRONIC OBSTRUCTIVE LUNG DISEASE IN LONDON AND IN CHICAGO. A STUDY OF ONE HUNDRED PATIENTS. Am Rev Respir Dis (1964) 1.33

Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med (1998) 1.30

The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med (1994) 1.29

Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis (1969) 1.26

The role of air pollution in asthma. Clin Exp Allergy (1993) 1.18

Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am J Respir Crit Care Med (1995) 1.14

Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis (1980) 1.14

NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci (1997) 1.04

Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis (1980) 1.03

Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest (1995) 1.01

Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis (1978) 0.99

The Tecumseh study of respiratory illness. VIII. Acute infection in chronic respiratory disease and comparison groups. Am Rev Respir Dis (1975) 0.97

Respiratory viral infections in hospital patients with chronic bronchitis. Observations during periods of exacerbation and quiescence. Chest (1973) 0.95

Pilot study of factors associated with exacerbations in chronic bronchitis. Br Med J (1969) 0.94

Viral antibody levels and clinical status in acute exacerbations of chronic bronchitis: a controlled prospective study. Br Med J (1968) 0.93

Viral infection in guinea pigs induces a sustained non-specific airway hyperresponsiveness and morphological changes of the respiratory tract. Eur J Pharmacol (1992) 0.92

Virus-induced airway hyperresponsiveness. Role of inflammatory cells and mediators. Am J Respir Crit Care Med (1995) 0.89

Course of chronic obstructive pulmonary disease following first onset of respiratory failure. Chest (1973) 0.88

Relationship of bacterial and viral infections to exacerbations of asthma. Thorax (1979) 0.87

Genetics of asthma: a review. Chest (1997) 0.86

Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections. Am J Respir Crit Care Med (1995) 0.86

Impact of respiratory virus infection in patients with chronic chest disease. Epidemiol Infect (1993) 0.81

Susceptibility to rhinovirus infection in chronic bronchitis. Am Rev Respir Dis (1978) 0.79

Etiology of upper-respiratory-tract illnesses among civilian adults. JAMA (1966) 0.78

Viral contributions to chronic obstructive respiratory disease. Possible mechanisms and approaches to detection. Yale J Biol Med (1968) 0.78

A search for mycoplasma infections in patients with chronic bronchitis. Thorax (1971) 0.78

Articles by these authors

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med (1999) 3.98

Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50

Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics (1983) 3.00

Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis (1997) 2.78

Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch Virol (1996) 2.11

A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparation. J Infect Dis (2000) 1.81

Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol (1998) 1.80

Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J Clin Microbiol (1997) 1.77

Real-time RT-PCR for norovirus screening in shellfish. J Virol Methods (2005) 1.75

Dual respiratory virus infections. Clin Infect Dis (1997) 1.67

Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens. J Clin Microbiol (2000) 1.66

Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis (2000) 1.66

Distribution of Norwalk virus within shellfish following bioaccumulation and subsequent depuration by detection using RT-PCR. J Food Prot (1998) 1.66

High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol (1994) 1.61

Detection and analysis of a small round-structured virus strain in oysters implicated in an outbreak of acute gastroenteritis. Appl Environ Microbiol (1996) 1.60

Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med (2001) 1.55

Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.53

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med (1991) 1.43

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. Vaccine (1999) 1.33

Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis (1998) 1.28

Development of an immunomagnetic capture reverse transcription-PCR assay for the detection of Norwalk virus. J Virol Methods (2000) 1.24

Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin Diagn Lab Immunol (1996) 1.22

Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis (1992) 1.18

Development of methods to detect "Norwalk-like viruses" (NLVs) and hepatitis A virus in delicatessen foods: application to a food-borne NLV outbreak. Appl Environ Microbiol (2000) 1.15

Granuloma cytokines in murine cysticercosis. Infect Immun (1997) 1.10

Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors. Clin Infect Dis (1998) 1.10

In situ detection of hepatitis A virus in cell cultures and shellfish tissues. Appl Environ Microbiol (1994) 1.09

Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic. Clin Vaccine Immunol (2010) 1.07

Unanticipated diagnoses found at autopsy in an urban public teaching hospital. Am J Med Sci (1996) 0.97

Development of a reverse transcription-PCR-DNA enzyme immunoassay for detection of "Norwalk-like" viruses and hepatitis A virus in stool and shellfish. Appl Environ Microbiol (2001) 0.97

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine (2009) 0.97

Characterization of norovirus-associated traveler's diarrhea. Clin Infect Dis (2010) 0.96

Vivax malaria complicated by adult respiratory distress syndrome. Clin Infect Dis (1999) 0.95

Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness. J Clin Microbiol (1994) 0.89

Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12. Mech Ageing Dev (1997) 0.87

Influenza A virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J (1999) 0.86

Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine (2001) 0.81

Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect (2009) 0.81

Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8. Epidemiol Infect (2003) 0.80

Re: Nosocomial outbreak of norovirus gastroenteritis and investigation of ABO histo-blood group type in infected staff and patients. J Hosp Infect (2004) 0.80

Diagnosis of respiratory viruses in cancer and transplant patients. Curr Clin Top Infect Dis (1999) 0.78

Ribavirin aerosol treatment of influenza B virus infection. Trans Assoc Am Physicians (1983) 0.75

Enforcing antimicrobial restrictions. Am J Health Syst Pharm (1996) 0.75

B-cell activation and differentiation by HIV-1 antigens among volunteers vaccinated with VaxSyn HIV-1. J Acquir Immune Defic Syndr (1992) 0.75